AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitab M 2 mg/500 mg Tablet

Prescription Icon
Prescription Required

Marketer

Centaur Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimitab M 2 mg/500 mg Tablet

Diabexe Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are vital for prevention. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glimitab M 2 mg/500 mg Tablet

Managing type 2 diabetes

Major Benefits of Glimitab M 2 mg/500 mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 2 mg/500 mg Glimitab M tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Glimitab M 2 mg/500 mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitab M 2 mg/500 mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimitab M 2 mg/500 mg tablets should be administered with a meal.

How Glimitab M 2 mg/500 mg Tablet works:

Glimepiride and Metformin 2 mg/500 mg tablets (Glimitab M) offer dual action against high blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimitab M 2 mg/500 mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimitab M 2 mg/500 mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimitab M 2 mg/500 mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Glimitab M 2 mg/500 mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is necessary. The medication is contraindicated in patients exhibiting severe kidney dysfunction. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimitab M 2 mg/500 mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiate treatment with a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimitab M 2 mg/500 mg Tablet :

Should you forget a Glimitab M 2 mg/500 mg Tablet dose, take it immediately if you remember. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitab M 2 mg/500 mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glimitab M 2 mg/500 mg Tablet

Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimitab M 2 mg/500 mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimitab M and seek immediate medical attention.
Glimitab M 2 mg/500 mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimitab M 2 mg/500 mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimitab M 2 mg/500 mg tablets can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimitab M 2 mg/500 mg Tablets can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimitab M 2 mg/500 mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimitab M 2 mg/500 mg Ta...
98
MRP 114
13% off